Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects

Parkinson’s disease (PD) symptoms have been collectively ascribed to malfunctioning of dopamine-related nigro-striatal and cortico-striatal loops. However, some doubts about this proposition are raised by controversies about the temporal progression of the impairments, and whether they are concomita...

Full description

Bibliographic Details
Main Authors: Rodrigo ePavão, André Frazão Helene, Gilberto Fernando Xavier
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-08-01
Series:Frontiers in Integrative Neuroscience
Subjects:
PD
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnint.2012.00056/full
id doaj-0afbbc65dcb4420786fb567944e2d5c0
record_format Article
spelling doaj-0afbbc65dcb4420786fb567944e2d5c02020-11-24T22:45:11ZengFrontiers Media S.A.Frontiers in Integrative Neuroscience1662-51452012-08-01610.3389/fnint.2012.0005629101Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effectsRodrigo ePavão0Rodrigo ePavão1André Frazão Helene2Gilberto Fernando Xavier3Universidade Federal do Rio Grande do NorteUniversidade de São PauloUniversidade de São PauloUniversidade de São PauloParkinson’s disease (PD) symptoms have been collectively ascribed to malfunctioning of dopamine-related nigro-striatal and cortico-striatal loops. However, some doubts about this proposition are raised by controversies about the temporal progression of the impairments, and whether they are concomitant or not. The present study consists of a systematic revision of literature data on both functional PD impairments and dopaminergic medication effects in order to draw a coherent picture about the disease progression. It was done in terms of an explanatory model for the disruption of implicit knowledge acquisition, motor and cognitive impairments, and the effects of dopaminergic medication on these functions. Cognitive impairments arise at early stages of PD and stabilizes while disruption of acquisition of implicit knowledge and motor impairments are still in progression; additionally, dopaminergic medication reduces motor impairments and increases disruption of acquisition of implicit knowledge. Since this model revealed consistency and plausibility when confronted with data of others studies not included in model's formulation, it may turn out to be a useful tool for understanding the multifaceted characteristics of PD.http://journal.frontiersin.org/Journal/10.3389/fnint.2012.00056/fullLevodopamodelingcognitive functionsprogressionPD
collection DOAJ
language English
format Article
sources DOAJ
author Rodrigo ePavão
Rodrigo ePavão
André Frazão Helene
Gilberto Fernando Xavier
spellingShingle Rodrigo ePavão
Rodrigo ePavão
André Frazão Helene
Gilberto Fernando Xavier
Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
Frontiers in Integrative Neuroscience
Levodopa
modeling
cognitive functions
progression
PD
author_facet Rodrigo ePavão
Rodrigo ePavão
André Frazão Helene
Gilberto Fernando Xavier
author_sort Rodrigo ePavão
title Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
title_short Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
title_full Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
title_fullStr Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
title_full_unstemmed Parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
title_sort parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects
publisher Frontiers Media S.A.
series Frontiers in Integrative Neuroscience
issn 1662-5145
publishDate 2012-08-01
description Parkinson’s disease (PD) symptoms have been collectively ascribed to malfunctioning of dopamine-related nigro-striatal and cortico-striatal loops. However, some doubts about this proposition are raised by controversies about the temporal progression of the impairments, and whether they are concomitant or not. The present study consists of a systematic revision of literature data on both functional PD impairments and dopaminergic medication effects in order to draw a coherent picture about the disease progression. It was done in terms of an explanatory model for the disruption of implicit knowledge acquisition, motor and cognitive impairments, and the effects of dopaminergic medication on these functions. Cognitive impairments arise at early stages of PD and stabilizes while disruption of acquisition of implicit knowledge and motor impairments are still in progression; additionally, dopaminergic medication reduces motor impairments and increases disruption of acquisition of implicit knowledge. Since this model revealed consistency and plausibility when confronted with data of others studies not included in model's formulation, it may turn out to be a useful tool for understanding the multifaceted characteristics of PD.
topic Levodopa
modeling
cognitive functions
progression
PD
url http://journal.frontiersin.org/Journal/10.3389/fnint.2012.00056/full
work_keys_str_mv AT rodrigoepavao parkinsonsdiseaseprogressionimplicitacquisitioncognitiveandmotorimpairmentsandmedicationeffects
AT rodrigoepavao parkinsonsdiseaseprogressionimplicitacquisitioncognitiveandmotorimpairmentsandmedicationeffects
AT andrefrazaohelene parkinsonsdiseaseprogressionimplicitacquisitioncognitiveandmotorimpairmentsandmedicationeffects
AT gilbertofernandoxavier parkinsonsdiseaseprogressionimplicitacquisitioncognitiveandmotorimpairmentsandmedicationeffects
_version_ 1725689723709554688